Fierce Healthcare October 18, 2018
Paige Minemyer

The Food and Drug Administration is looking at tech-based solutions to the opioid crisis, Commissioner Scott Gottlieb said.

The Food and Drug Administration plans to release new guidance for opioid prescribing, which it intends to use as the basis of new digital training tools for providers aimed at addressing the addiction epidemic.

Commissioner Scott Gottlieb, M.D., said staffers from the FDA will be meeting with the National Academy of Medicine in mid-November to start building a centralized hub of evidence-based guidelines for providers.

It would allow the FDA to use a digital tool to require physicians to undergo training before they could prescribe opioids in large amounts.

Physicians considering a 30-day supply of opioids, for...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: FDA, Govt Agencies, Provider, Regulations
FDA Approves Winrevair, Merck’s Novel Treatment for Pulmonary Arterial Hypertension
FDA approves Merck drug for rare lung disorder
Neuronetics wins FDA clearance for device to treat adolescents with depression
FDA Approves Roche’s Cobas Malaria Test, Designed to Screen for Malaria in Potential Blood Donors
Merck Drug for Heart and Lung Disorder Wins a First-in-Class FDA Approval

Share This Article